Long-term Rebamipide and Diquafosol in Two Cases of Immune-Mediated Dry Eye

PURPOSE: Two new drugs with mucin-inducing and secretion-promotive effects, rebamipide and diquafosol, were recently approved as topical dry-eye treatments. We report two cases in which the long-term use of mucin-inducing eye drops improved chronic ocular graft-versus-host disease (cGVHD)–related dr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Optom Vis Sci
Asıl Yazarlar: Yamane, Mio, Ogawa, Yoko, Fukui, Masaki, Kamoi, Mizuka, Saijo-Ban, Yumiko, Yaguchi, Saori, Mukai, Shin, Kawakita, Tetsuya, Simmura, Shigeto, Tsubota, Kazuo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lippincott Williams & Wilkins 2015
Konular:
Clinical Cases
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4376271/
https://ncbi.nlm.nih.gov/pubmed/25785527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/OPX.0000000000000523
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller